Niger vs North Macedonia: Previously treated cases tested for RR-/MDR-TB
Niger
33.0%
in 2024
North Macedonia
29.0%
in 2024
Niger rank
158th
North Macedonia rank
161st
Previously treated cases tested for RR-/MDR-TB over time
- Niger
- North Macedonia
How they compare
Niger currently reports 33.0% against 29.0% in North Macedonia, a difference of 4.0%.
That makes Niger's figure about 1.1 times North Macedonia's.
The two have swapped places 5 times across 16 shared years of data; in 2009 it was North Macedonia ahead.
Niger ranks 158th and North Macedonia ranks 161st of 180 countries.
North Macedonia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Niger | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.8% | 50.0% | 45.2% | North Macedonia |
| 2010s | 44.2% | 71.8% | 27.6% | North Macedonia |
| 2020s | 76.6% | 77.4% | 0.8% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Niger or North Macedonia?
- Niger, at 33.0% against 29.0% in North Macedonia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Niger and North Macedonia?
- 4.0%, with Niger ahead.
- How many years of comparable data are there for Niger and North Macedonia?
- 16 years are reported by both, from 2009 to 2024.
- How do Niger and North Macedonia rank globally for previously treated cases tested for rr-/mdr-tb?
- Niger ranks 158th and North Macedonia ranks 161st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.